Anu Chawla/LinkedIn
Jun 29, 2026, 11:44
Anu Chawla: PICSI in Focus, What the HABSelect Trial Revealed?
Anu Chawla, Chairperson at Federation of obstetrics and Gynaecological Societies of India, shared a post on LinkedIn:
- The HABSelect Trial is the largest randomised study evaluating PICSI.
- It included 2,722 couples across 16 UK fertility centres.
- PICSI did not significantly improve overall live birth rates compared with standard ICSI.
- PICSI was associated with a lower miscarriage rate (14% vs 22%), representing approximately a 38% relative reduction.
- Current international guidelines do not recommend routine PICSI for every patient, but selected individuals may benefit.
- Treatment decisions should always be personalised following discussion with a fertility specialist.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Aug 15, 2026, 18:00Lamia Sayegh: An Euploid Embryo Is Not the Whole Story…
-
Aug 15, 2026, 17:47Andreas Schallmoser: Age-Dependent Differences in the Utilisation of Ovarian Tissue Cryopreservation
-
Aug 15, 2026, 17:15New Study Examines the Link Between Obesity and Early Pregnancy Loss After Euploid FET
-
Aug 15, 2026, 16:43Mauro Cozzolino: Recipient Age and Reproductive Outcomes in Donor Oocyte Cycles
-
Aug 15, 2026, 16:33Palak Dewaan: Could the Bacteria in Semen Affect Your Chances of Having a Baby?
-
Aug 15, 2026, 14:51Diana Kayal: 1 of 9 Myths about IVF I Correct Most Often in My Clinic
-
Aug 15, 2026, 14:36Connie Stark: The Fertility Industry Solved the Invoice – It Never Solved the Exit…
-
Aug 15, 2026, 13:27Precious Chukwuemeka: IVF Improves the Chances of Pregnancy, but It Doesn’t Guarantee a Baby
-
Aug 15, 2026, 13:15Pratik Raj: Surgical Sperm Retrieval Techniques Used In Azoospermia And Severe Male-Factor Infertility